Arcadia Biosciences

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Arcadia Biosciences reports positive Q1 results, eyes revenue growth

Arcadia Biosciences delivered strong financial performance in Q1 2024, driven by revenue growth and cost management. The company faces challenges in retail execution but has opportunities for revenue growth through brand expansions and strategic partnerships.

Arcadia Biosciences reports strong Q2 driven by Zola growth

Arcadia Biosciences delivered solid financial performance in Q2 2024 driven by Zola Coconut Water.
Efficient cost-saving measures and strategic asset monetization bolstered profitability.
Challenges include managing increased costs and sustaining growth momentum.
Opportunities lie in expanding Zola brand, diversifying revenue streams, and strategic partnerships.

Arcadia Biosciences reports robust Q3 revenue growth driven by Zola

Arcadia Biosciences delivered strong revenue growth, particularly driven by Zola coconut water sales. Despite challenges in providing forward guidance, the company remains optimistic about Zola's performance and is focused on cost reduction and new product development to drive future growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX.

DAVIS, Calif. , May 5, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2022 after market close on May 12, 2022.

Arcadia Biosciences Announces Date of First Quarter 2022 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc. (RKDA) CEO Stan Jacot on Q4 2021 Results - Earnings Call Transcript

Arcadia Biosciences Inc (NASDAQ: RKDA) reported fourth-quarter revenue declined 70% year-over-year to $2.17 million, missing the consensus of $3.33 million. Net loss was $(9.3) million of $(0.42) per share, compared to the $8.9 million of income recognized in 4Q20, missing the consensus.

Arcadia Biosciences Shares Plunge Afterhours As Q4 Earnings Miss Estimates

– Strong balance sheet entering 2022 – – Expanded consumer product offerings in on-trend categories – – Experienced CPG talent added throughout organization – DAVIS, Calif. , March 30, 2022 /PRNewswire/ --  Arcadia Biosciences, Inc.

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights

DAVIS, Calif. , March 23, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its 2021 fourth-quarter and full-year financial and business results after market close on March 30, 2022.

Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2021 Financial Results and Business Highlights Conference Call

Agriforce Growing Systems Ltd

Marrone Bio Innovations

S&W Seed

Farming & Agriculture Penny Stocks To Watch Right Now. The post Best Penny Stocks To Buy?

Best Penny Stocks To Buy? 4 Agriculture & Farmings Stocks To Watch

Clearside Biomedical

Exicure Inc

Check these trending penny stocks out for your watchlist The post Good Trending Penny Stocks to Buy Now? Check These 3 Out  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Good Trending Penny Stocks to Buy Now? Check These 3 Out

Altamira Therapeutics Ltd

Humanigen

Kala Pharmaceuticals

Nasdaq Penny Stocks List For March The post 4 Nasdaq Penny Stocks To Buy For Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Nasdaq Penny Stocks To Buy For Under $5

AquaBounty Technologies

Exela Technologies

4 Hot Penny Stocks To Buy According To Analysts. The post 4 Penny Stocks With Huge Potential According To Analyst Forecasts appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Penny Stocks With Huge Potential According To Analyst Forecasts

DAVIS, Calif., Feb. 2, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, has appointed veteran consumer goods leader Stan Jacot as chief executive officer, effective today.

Arcadia Biosciences (RKDA) Names Stan Jacot as CEO

Diversified Healthcare Trust

NexTier Oilfield Solutions Inc

TOMI Environmental Solutions

Top penny stocks to buy according to analysts right now. The post 4 Top Penny Stocks Analysts Say To Buy Now& Targets Up To 408% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

4 Top Penny Stocks Analysts Say To Buy Now& Targets Up To 408%

DAVIS, Calif., Dec. 20, 2021 /PRNewswire/ --  Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced it has appointed Kevin Comcowich, current Chairman of the Arcadia Board of Directors, as interim chief executive officer, effective January 1, 2022, as the board of directors finalizes its search for a permanent CEO.

Arcadia Biosciences (RKDA) Appoints Kevin Comcowich to Interim CEO

Execution of sales strategies has lagged and the previously hoped for growth of the GoodHemp product line has not materialized. Now the company trades at cash with the market giving no credence to potential growth in the remaining product lines.

Arcadia Biosciences - An Update

DAVIS, Calif., Nov. 22, 2021 /PRNewswire/ --   Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced it has named Brian Schaffer as senior vice president of sales, as the company continues to expand its consumer goods platforms.

Arcadia Biosciences (RKDA) Appoints Seasoned CPG Sales Executive Brian Schaffer to Senior Vice President of Sales

Arcadia Biosciences' (RKDA) CEO Matt Plavan on Q3 2021 Results - Earnings Call Transcript

DAVIS, Calif., Nov. 15, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.

Arcadia Biosciences (RKDA) Announces Strong Third-Quarter Financial Results and Business Highlights

Arcadia Biosciences (NASDAQ:RKDA) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement.

Arcadia Biosciences Earnings Preview

DAVIS, Calif., Nov. 8, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter and first nine months of 2021 after market close on November 15, 2021.

Arcadia Biosciences (RKDA) Announces Date of Third-Quarter 2021 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc said it has launched a national search for a new CEO as the company further expands into the consumer packaged goods (CPG) sector. Current CEO Matt Plavan will step down from the role once a successor is named, which is expected to occur by the end of the year.

Arcadia Biosciences kicks off its search for a new CEO

DAVIS, Calif., Sept. 7, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that it has launched a national search for a new Chief Executive Officer as the company further expands into the consumer packaged goods sector.

Arcadia Biosciences Announces Leadership Transition

Arcadia Biosciences reported a five-fold increase in revenue in its second quarter, mainly thanks to sales from the newly acquired portfolio of wellness brands, as well as its GoodHemp seed sales. For the three months to June 30, the maker of plant-based health and wellness products reported revenue of $1.4 million, compared to $281,000 in 2Q, 2020.

Arcadia Biosciences sees five-fold revenue growth in 2Q as it records first consumer brand sales

Arcadia Biosciences' (RKDA) CEO Matt Plavan on Q2 2021 Results - Earnings Call Transcript

DAVIS, Calif., Aug. 16, 2021 /PRNewswire/ --  Arcadia Biosciences, Inc.

Arcadia Biosciences Announces Strong Second-Quarter and First-Half 2021 Financial Results and Business Highlights

DAVIS, Calif., Aug. 9, 2021 /PRNewswire/ -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half 2021 after market close on August 16, 2021.

Arcadia Biosciences (RKDA) Announces Date of Second-Quarter and First-Half 2021 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc. (NASDAQ:RKDA) has named Laura Pitlik its chief marketing officer, as the company expands its consumer goods platforms following several key acquisitions. A veteran consumer packaged goods strategist, the company said Pitlik will spearhead brand development and omnichannel marketing activities for Arcadia's portfolio of consumer nutrition, health and wellness brands.

Arcadia Biosciences names Laura Pitlik its chief marketing officer, as the company expands its consumer goods platforms following several key acquisitions

News for Arcadia Biosciences Stock (RKDA)